MIND News

DR. DANIEL SINGER DISCUSSES ALZHEIMER’S DIAGNOSIS AND NEW TREATMENTS AT BROWN CENTER EVENT

Dr. Daniel Singer, a neurologist at the Michigan Institute for Neurological Disorders (MIND), delivered a presentation on August 13, 2025, at the Dorothy & Peter Brown Jewish Community Adult Day Program in Southfield, Michigan.

The event, titled “Alzheimer’s Through the Stages: A Guide for Patients and Families,” aimed to assist Metro Detroit families in navigating an Alzheimer’s diagnosis, understanding available support, and learning about emerging FDA-approved treatments. According to the Alzheimer’s Association, approximately 203,000 individuals in Michigan are living with Alzheimer’s and other forms of dementia.

Dr. Singer emphasized the importance of early diagnosis, noting advancements such as PET scans, genetic tests, and blood tests that facilitate earlier detection. He discussed new FDA-approved medications, including monoclonal antibody infusions that help clear amyloid plaques in the brain, potentially slowing disease progression. Additionally, he highlighted the role of tau protein biomarkers in simplifying early diagnosis.

For more information on the Brown Adult Day Program and upcoming events, visit their official website.

Related articles: